In rats with stress-induced rheumatoid arthritis, daily eucalyptol at 200 mg/kg lowered levels of two inflammatory markers (TNF-α and IL-6) and raised levels of an anti-inflammatory marker (IL-10),...
Mechanism
Synthesis from 1 study
Eucalyptol blocks the body’s main inflammation switches in the joints, stopping the production of harmful signals and allowing a calming signal to rise. It also cleans up damaging molecules that would otherwise keep the inflammation going.
Most probable mechanism
Eucalyptol enters the bloodstream and reaches inflamed joints, where it blocks key signaling proteins that turn on inflammation genes. This stops the production of harmful signals like TNF-α and IL-6, while allowing the body to increase production of the calming signal IL-10. The reduction in oxidative stress from eucalyptol further prevents these inflammatory pathways from activating.
Eucalyptol enters systemic circulation and accumulates in joint tissues
Eucalyptol inhibits phosphorylation and nuclear translocation of NF-κB and activation of MAPK kinases (p38, JNK, ERK)
Inhibition of NF-κB and MAPK pathways reduces transcription of TNF-α and IL-6 genes
Reduced NF-κB and MAPK activity increases transcription of IL-10 gene
Eucalyptol directly scavenges reactive oxygen and nitrogen species and increases activity of superoxide dismutase and catalase
Lowered oxidative stress prevents activation of NF-κB and MAPK pathways and reduces tissue damage
Evidence from Studies
Supporting (1)
Community contributions welcome
Contradicting (0)
Community contributions welcome
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.